VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis

American Journal of Pathology

Volumn 184, Issue 4, 2014, Pages 1230-1239

  Yang, Zhihong ^a   Wang, Haibo ^a   Jiang, Yanchao ^a   Hartnett, M Elizabeth ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN RECEPTOR; LENTIVIRUS VECTOR; SEMAXANIB; SHORT HAIRPIN RNA; STAT3 PROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; SMALL INTERFERING RNA; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MICROVASCULAR ENDOTHELIAL CELL; MUELLER CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXYGEN-INDUCED RETINOPATHY; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; RETINA CELL; RETROLENTAL FIBROPLASIA; UPREGULATION; ANIMAL; DISEASE MODEL; GENE SILENCING; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ERYTHROPOIETIN; RETINOPATHY OF PREMATURITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84897046365     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.12.023     Document Type: Article

References (55)

1. C. Gilbert Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control Early Hum Dev 84 2008 77 82
2. M.E. Hartnett, and J.S. Penn Mechanisms and management of retinopathy of prematurity N Engl J Med 367 2012 2515 2526
3. L.E.H. Smith, E. Wesolowski, A. McLellan, S.K. Kostyk, R. D'Amato, R. Sullivan, and P.A. D'Amore Oxygen induced retinopathy in the mouse Invest Ophthalmol Vis Sci 35 1994 101 111
4. N. Ashton Retrolental fibroplasia now retinopathy of prematurity Br J Ophthalmol 68 1984 689
5. P.K. Shah, V. Narendran, and N. Kalpana Aggressive posterior retinopathy of prematurity in large preterm babies in South India Arch Dis Child Fetal Neonatal Ed 97 2012 F371 F375
6. E.A. Pierce, R.L. Avery, E.D. Foley, L.P. Aiello, and L.E.H. Smith Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization Proc Natl Acad Sci USA 92 1995 905 909
7. E. Pierce, E. Foley, and E.H. Lois Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity [Erratum appeared in Arch Ophthalmol 1997, 115:427] Arch Ophthalmol 114 1996 1219 1228
8. J.S. Penn, A. Madan, R.B. Caldwell, M. Bartoli, R.W. Caldwell, and M.E. Hartnett Vascular endothelial growth factor in eye disease Prog Retin Eye Res 27 2008 331 371
9. E.W.M. Ng, and A.P. Adamis Anti-VEGF aptamer (pegaptanib) therapy for ocular vascular diseases Ann N Y Acad Sci 1082 2006 151 171
10. N. Ferrara, L. Damico, N. Shams, H. Lowman, and R. Kim Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration Retina 26 2006 859 870
11. T. Chan-Ling, B. Gock, and J. Stone The effect of oxygen on vasoformative cell division: evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis Invest Ophthalmol Vis Sci 36 1995 1201 1214
12. J. Stone, A. Itin, T. Alon, J. Pe'er, H. Gnessin, T. Chan-Ling, and E. Keshet Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia J Neurosci 15 1995 4738 4747
13. H.A. Mintz-Hittner, K.A. Kennedy, A.Z. Chuang BEAT-ROP Cooperative Group Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity N Engl J Med 364 2011 603 615
14. J. Hu, M.P. Blair, M.J. Shapiro, S.J. Lichtenstein, J.M. Galasso, and R. Kapur Reactivation of retinopathy of prematurity after bevacizumab injection [Erratum appeared in Arch Ophthalmol 2013, 131:212] Arch Ophthalmol 130 2012 1000 1006
15. M. McCloskey, H. Wang, Y. Jiang, G.W. Smith, J. Strange, and M.E. Hartnett Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity Invest Ophthalmol Vis Sci 54 2013 2020 2026
16. R.G. Strauss Anaemia of prematurity: pathophysiology and treatment Blood Rev 24 2010 221 225
17. M. Digicaylioglu, and S.A. Lipton Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades Nature 412 2001 641 647
18. S. Erbayraktar, G. Grasso, A. Sfacteria, Q.W. Xie, T. Coleman, M. Kreilgaard, L. Torup, T. Sager, Z. Erbayraktar, N. Gokmen, O. Yilmaz, P. Ghezzi, P. Villa, M. Fratelli, S. Casagrande, M. Leist, L. Helboe, J. Gerwien, S. Christensen, M.A. Geist, L. Pedersen, C. Cerami-Hand, J.P. Wuerth, A. Cerami, and M. Brines Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo [Erratum appeared in Proc Natl Acad Sci USA 2003, 100:9102] Proc Natl Acad Sci USA 100 2003 6741 6746
19. M. Leist, P. Ghezzi, G. Grasso, R. Bianchi, P. Villa, M. Fratelli, C. Savino, M. Bianchi, J. Nielsen, J. Gerwien, P. Kallunki, A.K. Larsen, L. Helboe, S. Christensen, L. Pedersen, M. Nielsen, L. Torup, T. Sager, A. Sfacteria, S. Erbayraktar, Z. Erbayraktar, N. Gokmen, O. Yilmaz, C. Cerami-Hand, Q. Xie, T. Coleman, A. Cerami, and M. Brines Derivatives of erythropoietin that are tissue protective but not erythropoietic Science 305 2004 239 242
20. Q. Wang, F. Pfister, A. Dorn-Beineke, F. vom Hagen, J. Lin, Y. Feng, and H.P. Hammes Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina Diabetologia 53 2010 1227 1238
21. E. Guneli, Z. Cavdar, H. Islekel, S. Sarioglu, S. Erbayraktar, M. Kiray, S. Sokmen, O. Yilmaz, and N. Gokmen Erythropoietin protects the intestine against ischemia/reperfusion injury in rats Mol Med 13 2007 509 517
22. N. Kertesz, J. Wu, T.H.P. Chen, H.M. Sucov, and H. Wu The role of erythropoietin in regulating angiogenesis Dev Biol 276 2004 101 110
23. M. Nakano, K. Satoh, Y. Fukumoto, Y. Ito, Y. Kagaya, N. Ishii, K. Sugamura, and H. Shimokawa Important role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in mice Circ Res 100 2007 662 669
24. Y. Bennis, G. Sarlon-Bartoli, B. Guillet, L. Lucas, L. Pellegrini, L. Velly, M. Blot-Chabaud, F. Dignat-Georges, F. Sabatier, and P. Pisano Priming of late endothelial progenitor cells with erythropoietin before transplantation requires the CD131 receptor subunit and enhances their angiogenic potential J Thromb Haemost 10 2012 1914 1928
25. D. Watanabe, K. Suzuma, S. Matsui, M. Kurimoto, J. Kiryu, M. Kita, I. Suzuma, H. Ohashi, T. Ojima, T. Murakami, T. Kobayashi, S. Masuda, M. Nagao, N. Yoshimura, and H. Takagi Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy N Engl J Med 353 2005 782 792
26. Z. Tong, Z. Yang, S. Patel, H. Chen, D. Gibbs, and X. Yang et al. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications Proc Natl Acad Sci USA 105 2008 6998 7003
27. K.K. Suk, J.A. Dunbar, A. Liu, N.S. Daher, C.K. Leng, J.K. Leng, P. Lim, S. Weller, and E. Fayard Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model J AAPOS 12 2008 233 238
28. M.S. Brown, A.E. Barón, E.K. France, and R.F. Hamman Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity J AAPOS 10 2006 143 149
29. J. Chen, K.M. Connor, C.M. Aderman, and L.E. Smith Erythropoietin deficiency decreases vascular stability in mice J Clin Invest 118 2008 526 533
30. J. Chen, K.M. Connor, C.M. Aderman, K.L. Willett, O.P. Aspegren, and L.E.H. Smith Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy Invest Ophthalmol Vis Sci 50 2009 1329 1335
31. M. Morita, O. Ohneda, T. Yamashita, S. Takahashi, N. Suzuki, O. Nakajima, S. Kawauchi, M. Ema, S. Shibahara, T. Udono, K. Tomita, M. Tamai, K. Sogawa, M. Yamamoto, and Y. Fujii-Kuriyama HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin EMBO J 22 2003 1134 1146
32. H. Wang, G. Byfield, Y. Jiang, G.W. Smith, M. McCloskey, and M.E. Hartnett VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression Am J Pathol 180 2012 1243 1253
33. R.K. Ohls, R.D. Christensen, B.D. Kamath-Rayne, A. Rosenberg, S.E. Wiedmeier, M. Roohi, C.B. Lacy, D.K. Lambert, J.J. Burnett, B. Pruckler, R. Schrader, and J.R. Lowe A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants Pediatrics 132 2013 e119 e127
34. J.S. Penn, B.L. Tolman, and L.A. Lowery Variable oxygen exposure causes preretinal neovascularisation in the newborn rat Invest Ophthalmol Vis Sci 34 1993 576 585
35. S. Budd, G. Byfield, D. Martiniuk, P. Geisen, and M.E. Hartnett Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP Exp Eye Res 89 2009 718 727
36. H. Wang, G.W. Smith, Z. Yang, Y. Jiang, M. McCloskey, K. Greenberg, P. Geisen, W.D. Culp, J. Flannery, T. Kafri, S. Hammond, and M.E. Hartnett Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity Am J Pathol 183 2013 964 974
37. S.J. Budd, H. Thompson, and M.E. Hartnett Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity Arch Ophthalmol 128 2010 1014 1021
38. S.J. Budd, and M.E. Hartnett Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity Arch Ophthalmol 128 2010 589 595
39. Y. Saito, A. Uppal, G. Byfield, S. Budd, and M.E. Hartnett Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model Invest Ophthalmol Vis Sci 49 2008 1591 1598
40. V.A. Carroll, and M. Ashcroft Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway Cancer Res 66 2006 6264 6270
41. S. Frede, P. Freitag, L. Geuting, R. Konietzny, and J. Fandrey Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC Blood 117 2011 4905 4914
42. L.C. Ewan, H.M. Jopling, H. Jia, S. Mittar, A. Bagherzadeh, G.J. Howell, J.H. Walker, I.C. Zachary, and S. Ponnambalam Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells Traffic 7 2006 1270 1282
43. G. Byfield, S. Budd, and M.E. Hartnett The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model Invest Ophthalmol Vis Sci 50 2009 3360 3365
44. B.A. Berkowitz, and W. Zhang Significant reduction of the panretinal oxygenation response after 28% supplemental oxygen recovery in experimental ROP Invest Ophthalmol Vis Sci 41 2000 1925 1931
45. A. Ohlsson, and S.M. Aher Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants Cochrane Database Syst Rev 9 2012 CD004863
46. M. Aapro, W. Jelkmann, S.N. Constantinescu, and B. Leyland-Jones Effects of erythropoietin receptors and erythropoiesis-stimulating agents on disease progression in cancer Br J Cancer 106 2012 1249 1258
47. A.K. Junk, A. Mammis, S.I. Savitz, M. Singh, S. Roth, S. Malhotra, P.S. Rosenbaum, A. Cerami, M. Brines, and D.M. Rosenbaum Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury Proc Natl Acad Sci USA 99 2002 10659 10664
48. M. Brines, and A. Cerami Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise Kidney Int 70 2006 246 250
49. J.E. Sears, G. Hoppe, Q. Ebrahem, and B. Anand-Apte Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy Proc Natl Acad Sci USA 105 2008 19898 19903
50. G. Trichonas, T.J. Lee, G. Hoppe, J. Au, and J.E. Sears Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy in the rat 50/10 model Invest Ophthalmol Vis Sci 54 2013 4919 4926
51. Cryotherapy for Retinopathy of Prematurity Cooperative Group Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g Arch Ophthalmol 120 2002 595 599
52. J.T. Flynn Retinopathy of prematurity Pediatr Clin North Am 34 1987 1487 1516
53. G. Paragh, S.M. Kumar, Z. Rakosy, S.C. Choi, X. Xu, and G. Acs RNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cells Am J Pathol 174 2009 1504 1514
54. T. Morita, and S. Kourembanas Endothelial cell expression of vasconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide J Clin Invest 96 1999 2676 2682
55. K. Satoh, Y. Kagaya, M. Nakano, Y. Ito, J. Ohta, H. Tada, A. Karibe, N. Minegishi, N. Suzuki, M. Yamamoto, M. Ono, J. Watanabe, K. Shirato, N. Ishii, K. Sugamura, and H. Shimokawa Important role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in mice Circulation 113 2006 1442 1450